Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia

Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia

ABSTRACTObjective The complex pathogenesis of relapsed and refractory (R/R) immune thrombocytopenia (ITP) contributes to the varied efficacy and tolerability of current treatment regimens. Rapamycin, an immunomodulatory agent, was originally used in the prevention of organ rejection after organ tran...

Full description

Bibliographic Details
Main Authors: Dan Wang, Kaniel Cassady, Zhongmin Zou, Xi Zhang, Yimei Feng
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
Rapamycin
ITP
immune tolerance
autophagy
adverse effects
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2151230

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2151230

Similar Items